EP 2448572 A1 20120509 - METHODS OF IDENTIFYING A PATIENT POPULATION ELIGIBLE FOR TREATMENT WITH NITRIC OXIDE VIA INHALATION
Title (en)
METHODS OF IDENTIFYING A PATIENT POPULATION ELIGIBLE FOR TREATMENT WITH NITRIC OXIDE VIA INHALATION
Title (de)
VERFAHREN ZUR IDENTIFZIERUNG EINER FÜR EINE INHALATIVE BEHANDLUNG MIT STICKOXID GEEIGNETEN PATIENTENPOPULATION
Title (fr)
PROCÉDÉS D'IDENTIFICATION D'UNE POPULATION DE PATIENTS ÉLIGIBLES POUR LE TRAITEMENT AVEC DE L'OXYDE NITRIQUE PAR INHALATION
Publication
Application
Priority
- US 2010038652 W 20100615
- US 49459809 A 20090630
Abstract (en)
[origin: CA3130908A1] The inverrion relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.
IPC 8 full level
A61K 31/21 (2006.01); A61K 33/00 (2006.01); A61K 45/06 (2006.01); A61P 9/08 (2006.01); A61P 9/12 (2006.01)
CPC (source: EP US)
A61B 5/02007 (2013.01 - EP US); A61B 5/0205 (2013.01 - EP US); A61B 5/08 (2013.01 - EP US); A61B 5/4839 (2013.01 - EP US); A61B 5/7275 (2013.01 - EP US); A61B 5/7278 (2013.01 - US); A61B 8/0883 (2013.01 - US); A61B 8/48 (2013.01 - US); A61K 31/04 (2013.01 - EP US); A61K 31/21 (2013.01 - EP US); A61K 33/00 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61M 16/0057 (2013.01 - US); A61M 16/104 (2013.01 - US); A61M 16/12 (2013.01 - US); A61M 60/139 (2021.01 - EP US); A61M 60/295 (2021.01 - EP US); A61M 60/497 (2021.01 - EP US); A61M 60/841 (2021.01 - EP US); A61M 60/857 (2021.01 - EP US); A61P 9/00 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/00 (2017.12 - EP); G06Q 99/00 (2013.01 - EP US); F17C 2201/058 (2013.01 - EP US); F17C 2203/0646 (2013.01 - EP US); F17C 2221/014 (2013.01 - EP US); F17C 2221/03 (2013.01 - EP US); F17C 2223/0123 (2013.01 - EP US); F17C 2223/036 (2013.01 - EP US); F17C 2270/025 (2013.01 - EP US); G16H 20/10 (2017.12 - EP US)
C-Set (source: EP US)
EP
US
Citation (search report)
See references of WO 2011002606A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
AU 2010202422 A1 20100902; AU 2010202422 B2 20101021; AU 2009202685 B1 20100819; AU 2010206032 A1 20100902; AU 2010206032 B2 20111208; CA 2671029 A1 20101230; CA 3130908 A1 20101230; EP 2269614 A1 20110105; EP 2448572 A1 20120509; EP 2540304 A1 20130102; JP 2011010865 A 20110120; JP 2011011059 A 20110120; JP 2011251155 A 20111215; MX 2010006055 A 20110316; US 11931377 B2 20240319; US 2010330193 A1 20101230; US 2010330206 A1 20101230; US 2010330207 A1 20101230; US 2010331405 A1 20101230; US 2013040000 A1 20130214; US 2013068223 A1 20130321; US 2013074839 A1 20130328; US 2013078321 A1 20130328; US 2014338665 A1 20141120; US 2014348955 A1 20141127; US 2014377378 A1 20141225; US 2019231814 A1 20190801; US 8282966 B2 20121009; US 8293284 B2 20121023; US 8431163 B2 20130430; US 8795741 B2 20140805; US 8846112 B2 20140930; WO 2011002606 A1 20110106; WO 2011002606 A8 20110811
DOCDB simple family (application)
AU 2010202422 A 20100610; AU 2009202685 A 20090702; AU 2010206032 A 20100729; CA 2671029 A 20090702; CA 3130908 A 20090702; EP 09251949 A 20090806; EP 10724231 A 20100615; EP 12186399 A 20090806; JP 2009157623 A 20090702; JP 2010139671 A 20100618; JP 2011175996 A 20110811; MX 2010006055 A 20100602; US 2010038652 W 20100615; US 201213651660 A 20121015; US 201213683236 A 20121121; US 201213683417 A 20121121; US 201213683444 A 20121121; US 201414451057 A 20140804; US 201414454373 A 20140807; US 201414482704 A 20140910; US 201916378361 A 20190408; US 82086610 A 20100622; US 82098010 A 20100622; US 82102010 A 20100622; US 82104110 A 20100622